Ocugen, Inc. (NASDAQ:OCGN) shares are trading higher after the White House announced it would immediately make available specific raw materials needed by India to make COVID-19 vaccines.

Ocugen is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies. The company has a COVID-19 vaccine co-development partner, Bharat Biotech, which is located in India.

Ocugen's stock was trading approximately 19% higher to $11.44 on Monday at the time of publication. The stock has a 52-week high of $18.77 and a 52-week low of $0.17.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.